Literature DB >> 2396268

Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats.

S Imaizumi1, V Woolworth, R A Fishman, P H Chan.   

Abstract

We studied the role of superoxide radicals in the pathogenesis of ischemic brain injury using a model of focal cerebral ischemia in 102 rats and liposome-entrapped CuZn-superoxide dismutase, which can penetrate the blood-brain barrier and cell membranes efficiently. The bolus intravenous administration of 25,000 units of liposome-entrapped CuZn-superoxide dismutase elevated superoxide dismutase activities in the blood and brain 1, 2, 8, and 24 hours later as well as in the ischemic hemisphere and contralateral cortex. Determined 24 hours after right middle cerebral and bilateral common carotid artery occlusion by the lack of staining for mitochondrial dehydrogenase activity with 2,3,5-triphenyltetrazolium chloride, infarct sizes were reduced by 33%, 25%, and 18% in the anterior, middle, and posterior brain slices, respectively, by treatment with liposome-entrapped CuZn-superoxide dismutase. Our data demonstrate that superoxide radicals are important determinants of infarct size following focal cerebral ischemia and that liposome-entrapped CuZn-superoxide dismutase may have pharmacologic value for the treatment of focal cerebral ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2396268     DOI: 10.1161/01.str.21.9.1312

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

Authors:  M R Niesman; K A Johnson; J S Penn
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Gene therapy using SOD1 protects striatal neurons from experimental stroke.

Authors:  Alexis S Davis; Heng Zhao; Guo Hua Sun; Robert M Sapolsky; Gary K Steinberg
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

Review 3.  Neuronal death/survival signaling pathways in cerebral ischemia.

Authors:  Taku Sugawara; Miki Fujimura; Nobuo Noshita; Gyung Whan Kim; Atsushi Saito; Takeshi Hayashi; Purnima Narasimhan; Carolina M Maier; Pak H Chan
Journal:  NeuroRx       Date:  2004-01

Review 4.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 5.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

6.  Liposome-entrapped superoxide dismutase reduces ischemia/reperfusion 'oxidative stress' in gerbil brain.

Authors:  D B Stanimirovic; M Markovic; D V Micic; M Spatz; B B Mrsulja
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

7.  Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury.

Authors:  Xiang Yun; Victor D Maximov; Jin Yu; Hong Zhu; Alexey A Vertegel; Mark S Kindy
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

Review 8.  Mechanisms of radiation-induced brain toxicity and implications for future clinical trials.

Authors:  Jae Ho Kim; Stephen L Brown; Kenneth A Jenrow; Samuel Ryu
Journal:  J Neurooncol       Date:  2008-01-22       Impact factor: 4.130

9.  Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

Authors:  Devika S Manickam; Anna M Brynskikh; Jennifer L Kopanic; Paul L Sorgen; Natalia L Klyachko; Elena V Batrakova; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2012-08-10       Impact factor: 9.776

10.  Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion.

Authors:  P K Liu; C Y Hsu; M Dizdaroglu; R A Floyd; Y W Kow; A Karakaya; L E Rabow; J K Cui
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.